Sapidyne Instruments GmbH
  • Home
  • Products
    • KinExA 4000
    • KinExA 3200 >
      • Autosampler
    • Consumables
    • Parts & Accessories
    • Request A Quote
  • Technology
    • Applications >
      • Affinity & Kinetics
      • Immunoassay
      • Measurement Capabilities >
        • Antibodies
        • Cells
        • Small Molecules
        • Proteins
        • DNA & Aptamers
        • Lipids
        • Viruses & Toxins
        • Serum
        • & More
    • The KinExA Advantage
    • KinExA Pro Software
    • KinExA Video
    • Request A Presentation
  • Contract Research
  • Resources
    • Theory Curve
    • KinExA Training Videos
    • Tech Notes
    • How To Guides
    • Installation Instructions
    • KinExA Manual
    • References
    • Newsletters
  • Contact
Trusted Accuracy | Proven Reliability | Unrivaled Sensitivity
Picture
KinExA 4000
For over 25 years KinExA Technology has been used to detect & measure biological interactions in the most physiologically relevant conditions. Industry leading accuracy and sensitivity into the femtomolar range make KinExA an integral part of the lead identification and optimization process. Single-click analysis using KinExA Pro software is the gold standard for accurate affinity and kinetics data.
Equilibrium Dissociation Constant (Kd) | Association Rate Constant (Kon) | Dissociation Rate Constant (Koff)
Concentration Immunoassay | Rapid PAH Detection
"By tailoring the KinExA to each studied antigen, we obtained apparent equilibrium dissociation constants (K(D) values) spanning six orders of magnitude, from approximately 100 fM to 100 nM."
Bee C. et. al. 2012 Exploring the dynamic range of the kinetic exclusion assay in characterizing antigen-antibody interactions. PLOS ONE 7(4) 
​http://www.ncbi.nlm.nih.gov/pubmed/22558410
Picture
Picture
"The kinetics of binding and affinity of the 4 chimeric clones to human IL-21 were determined using a kinetic exclusion assay (KinExA)...Among the four lead clones, 19E3 had the highest affinity to recombinant human IL-21 of 243 fM"
Reena Varkey et. al. 2019 Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. 
PLOS ONE  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211236

Home

Products

KinExA 

CRO

Resources

Our Story

Contact

Events

Privacy Policy
Terms & Conditions
Copyright © 2022
  • Home
  • Products
    • KinExA 4000
    • KinExA 3200 >
      • Autosampler
    • Consumables
    • Parts & Accessories
    • Request A Quote
  • Technology
    • Applications >
      • Affinity & Kinetics
      • Immunoassay
      • Measurement Capabilities >
        • Antibodies
        • Cells
        • Small Molecules
        • Proteins
        • DNA & Aptamers
        • Lipids
        • Viruses & Toxins
        • Serum
        • & More
    • The KinExA Advantage
    • KinExA Pro Software
    • KinExA Video
    • Request A Presentation
  • Contract Research
  • Resources
    • Theory Curve
    • KinExA Training Videos
    • Tech Notes
    • How To Guides
    • Installation Instructions
    • KinExA Manual
    • References
    • Newsletters
  • Contact